Cargando…

Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors

Detalles Bibliográficos
Autores principales:	Juratli, Tareq A., Jungk, Christine, Miller, Julie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227136/ https://www.ncbi.nlm.nih.gov/pubmed/37212938 http://dx.doi.org/10.1007/s11060-023-04317-3

Ejemplares similares

Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community
por: Aldape, Kenneth, et al.
Publicado: (2017)

World Cancer Day 2021 - Perspectives in Pediatric and Adult Neuro-Oncology
por: Sulman, Erik P., et al.
Publicado: (2021)

Editorial: Insights in neuro-oncology and neurosurgical oncology: 2021
por: Sulman, Erik P., et al.
Publicado: (2023)

New Year’s greeting and overview of World Journal of Clinical Oncology in 2021
por: Gong, Ze-Mao, et al.
Publicado: (2021)

Editorial: Rising stars in neuro-oncology and neurosurgical oncology 2021
por: Edwards, Lincoln, et al.
Publicado: (2022)

Proteome-based insights for IDH-mutant glioma classification
por: Leu, Severina, et al.
Publicado: (2023)

Increased Radiation-Associated T-Cell Infiltration in Recurrent IDH-Mutant Glioma
por: Makarevic, Anastasia, et al.
Publicado: (2020)

The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1
por: Yoon, Hong In, et al.
Publicado: (2021)

INNV-40. REAL WORLD INTEGRATION OF THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN CLINICAL PRACTICE IN PATIENTS WITH IDH-WT GBM
por: Lim-Fat, Mary Jane, et al.
Publicado: (2021)

The 2021 World Health Organization classification of gliomas: an imaging approach
por: Fernandes, Renata Tarraf, et al.
Publicado: (2023)

Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

GLIOMA-07 E.R.A.S. IN NEURO-ONCOLOGY
por: Moro, Mario
Publicado: (2023)

Pediatric high-grade gliomas and the WHO CNS Tumor Classification—Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates
por: Gielen, Gerrit H, et al.
Publicado: (2022)

Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology
por: Ramakrishna, Rohan, et al.
Publicado: (2020)

Comparative analysis of transcriptomic profile, histology, and IDH mutation for classification of gliomas
por: Tran, Paul M. H., et al.
Publicado: (2020)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

Neuro-Oncology Practice in 2021: Covid-19, telemedicine, and beyond
por: Roth, Patrick
Publicado: (2021)

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline
por: Sahm, Felix, et al.
Publicado: (2023)

Biomarker Research in World Journal of Oncology
por: Takabe, Kazuaki, et al.
Publicado: (2023)

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma()()
por: Stasik, Sebastian, et al.
Publicado: (2020)

Editorial: The Role of Modern Neuro-oncology in the Treatment of Primary CNS Tumors, and Brain and Spinal Metastases
por: Maldaun, Marcos, et al.
Publicado: (2020)

Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)

A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4
por: Williams, Erik A., et al.
Publicado: (2023)

Contribution of CNS cells in NeuroAIDS
por: Verma, Ashish Swarup, et al.
Publicado: (2010)

Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors
por: Baugh, Joshua N, et al.
Publicado: (2021)

Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics
por: Śledzińska, Paulina, et al.
Publicado: (2022)

Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3
por: Eichkorn, Tanja, et al.
Publicado: (2023)

Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations
por: Persico, Pasquale, et al.
Publicado: (2022)

Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update
por: Whitfield, Benjamin T., et al.
Publicado: (2022)

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

The International Journal of Oncology: 30 years of progress (1992-2021)
por: Spandidos, Demetrios A.
Publicado: (2021)

Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study
por: Fischl, Anna, et al.
Publicado: (2023)

Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma
por: Lazaridis, Lazaros, et al.
Publicado: (2022)

Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification
por: Zakharova, Galina, et al.
Publicado: (2022)

Molecular Pathology of Neuro-AIDS (CNS-HIV)
por: Crews, Leslie, et al.
Publicado: (2009)

Skeletal muscle activity and CNS neuro-plasticity
por: Zhorne, Rachel, et al.
Publicado: (2016)

Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges
por: Luzzi, Sabino, et al.
Publicado: (2020)

Multi-institutional noninvasive in vivo characterization of IDH, 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk)
por: Rathore, Saima, et al.
Publicado: (2021)

Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology
por: Sturm, Dominik, et al.
Publicado: (2023)

Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm
por: Issa, Ghayas C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7qqhru5f9qe6n6hlcungql0vfe